OneSource Specialty Pharma Limited (ONESOURCE) Income Statement
0 Followers
OneSource Specialty Pharma Limited Income Statement
Last quarter (Q2 2025), OneSource Specialty Pharma Limited's total revenue was ₹3.76B, a decrease of -11.78% from previous quarter. In Q2, OneSource Specialty Pharma Limited's net income was ₹104.85M. See OneSource Specialty Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25
Mar 25
Total Revenue
₹ 14.45B
₹ 14.22B
Gross Profit
₹ 10.10B
₹ 4.56B
Operating Expenses
₹ 8.19B
₹ 4.30B
Depreciation and Amortization
₹ 2.74B
₹ 2.79B
EBITDA
₹ 3.61B
₹ 3.04B
Operating Income
₹ 1.90B
₹ 251.29M
Other Income/Expenses
₹ -2.58B
₹ -1.17B
Pretax Income
-
₹ -919.61M
Net Income
₹ -2.10M
₹ -738.03M
Per Share Metrics
Basic EPS
₹ -0.02
₹ -6.44
Diluted EPS
₹ -0.02
₹ -6.44
Weighted Average Shares Outstanding
110.40M
114.60M
Weighted Average Shares Outstanding (Diluted)
110.40M
114.60M
Currency in INR
OneSource Specialty Pharma Limited Earnings and Revenue History